Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

APRIL and TACI interact with syndecan‐1 on the surface of multiple myeloma cells to form an essential survival loop

View through CrossRef
AbstractBLyS and APRIL share two receptors – transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B‐cell maturation antigen (BCMA) – and BLyS binds to a third receptor, BAFF‐R. We previously reported that TACI gene expression is a good indicator of a BLyS‐binding receptor in human multiple myeloma cell lines (HMCLs), unlike BCMA, which is expressed by all HMCLs or BAFF‐R which is typically not expressed by late‐stage B cells. We hypothesised a link between APRIL and TACI through syndecan‐1, similar to the situation reported for FGF and FGFR. We observed very strong binding of APRIL, but not BLyS, at the surface of all syndecan‐1+ HMCLs and primary multiple myeloma cells (MMC). All syndecan‐1+ HMCLs and MMC could also bind TACI‐Fc, but not BCMA‐Fc or BAFF‐R‐Fc molecules. Binding of APRIL or TACI‐Fc was abrogated by heparin or cell pretreatment with heparitinase, which cleaves heparan sulfate chains. The growth factor activity of APRIL on MMC was also inhibited by heparin. Our data identify syndecan‐1 as a co‐receptor for APRIL and TACI at the cell surface of MMC, promoting the activation of an APRIL/TACI pathway that induces survival and proliferation in MMC.
Title: APRIL and TACI interact with syndecan‐1 on the surface of multiple myeloma cells to form an essential survival loop
Description:
AbstractBLyS and APRIL share two receptors – transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) and B‐cell maturation antigen (BCMA) – and BLyS binds to a third receptor, BAFF‐R.
We previously reported that TACI gene expression is a good indicator of a BLyS‐binding receptor in human multiple myeloma cell lines (HMCLs), unlike BCMA, which is expressed by all HMCLs or BAFF‐R which is typically not expressed by late‐stage B cells.
We hypothesised a link between APRIL and TACI through syndecan‐1, similar to the situation reported for FGF and FGFR.
We observed very strong binding of APRIL, but not BLyS, at the surface of all syndecan‐1+ HMCLs and primary multiple myeloma cells (MMC).
All syndecan‐1+ HMCLs and MMC could also bind TACI‐Fc, but not BCMA‐Fc or BAFF‐R‐Fc molecules.
Binding of APRIL or TACI‐Fc was abrogated by heparin or cell pretreatment with heparitinase, which cleaves heparan sulfate chains.
The growth factor activity of APRIL on MMC was also inhibited by heparin.
Our data identify syndecan‐1 as a co‐receptor for APRIL and TACI at the cell surface of MMC, promoting the activation of an APRIL/TACI pathway that induces survival and proliferation in MMC.

Related Results

Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.
Binding of TACI and APRIL to Syndecan-1 Confer on Them a Major Role in Multiple Myeloma.
Abstract B-cell activating factor (BAFF) and A Proliferation-Inducing Ligand (APRIL) are produced by the bone marrow microenvironment of patients with multiple myelo...
Data from Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma
Data from Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma
<div>Abstract<p>Syndecans are transmembrane heparan sulfate proteoglycans controlling cell adhesion, migration, and proliferation. We previously showed that syndecan-2 ...
Data from Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma
Data from Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma
<div>Abstract<p>Syndecans are transmembrane heparan sulfate proteoglycans controlling cell adhesion, migration, and proliferation. We previously showed that syndecan-2 ...
Epithelial Syndecan-1 Expression Is Associated with Stage and Grade in Colorectal Cancer
Epithelial Syndecan-1 Expression Is Associated with Stage and Grade in Colorectal Cancer
<i>Objectives:</i> Loss of epithelial heparan sulfate proteoglycan syndecan-1 has been associated with a more aggressive behavior in various cancer forms, but the progn...
MAF Protein Elicits Innate Resistance To Bortezomib In Multiple Myeloma
MAF Protein Elicits Innate Resistance To Bortezomib In Multiple Myeloma
Abstract Multiple myeloma (MM) is a malignancy of terminally differentiated clonal plasma cells displaying significant molecular heterogeneity with 7 subgroups defin...
Molecular Mechanisms Regulating BAFF and APRIL Receptor Expression in B Cells: Promoter Structure and Epigenetics
Molecular Mechanisms Regulating BAFF and APRIL Receptor Expression in B Cells: Promoter Structure and Epigenetics
Abstract Throughout differentiation, mature B cells express distinct combinations of the BAFF and APRIL receptors, BAFF-R, TACI, and BCMA. The patterns of B lineage ...
APRIL is overexpressed in cancer: link with tumor progression
APRIL is overexpressed in cancer: link with tumor progression
Abstract Background BAFF and APRIL share two receptors – TACI and BCMA – and BAFF binds to a third receptor, BAFF-R. Increased expression of BAFF...

Back to Top